Contact Us Today Button (demo)

Explore how Dotmatics' new Antibody Engineering software platform, featured in Fierce Biotech, uses AI-driven tools to accelerate and optimize R&D for life sciences, enhancing antibody design and development. Read the full article to learn more.

Fierce Biotech: Dotmatics debuts antibody engineering R&D software platform

fierce-biotech-feature

Discover how Dotmatics is accelerating drug development and breaking down data silos with the launch of Geneious Luma, as featured in VentureBeat. Read the full article and learn more about this cutting-edge AI platform.

VentureBeat: Dotmatics aims to speed drug development, break data silos with Geneious Luma

Dotmatics-VentureBeat


Introducing the first in a series of Dotmatics Luma Multimodal R&D Solutions. 

Luma Antibody & Protein Engineering Solution for End-to-End Antibody Discovery

PR-Antibody and Protein Engineering Solution

Dotmatics Introduces Luma Antibody & Protein Engineering Solution for End-to-End Antibody Discovery

Discover how Dotmatics' AI-powered software is driving innovation in life sciences across the APAC region, empowering researchers with cutting-edge tools for faster, smarter decision-making.

International Business Times: Meet Dotmatics, Powering Life Sciences Breakthroughs with AI

International Business Times featured article

International Business Times: Meet Dotmatics, the AI Software Company Powering APAC Life Sciences Breakthroughs

PR-Virscidian

Dotmatics’ 15th acquisition builds on its strategy to offer the industry’s best-in-class scientific applications built by scientists for scientists that integrate with the Luma Scientific Intelligence Platform.

Dotmatics Acquires Virscidian, Expanding Expertise in Analytical Chemistry and Chromatography and Mass Spectrometry

PR-Swartz-CSO

As CSO, Michael Swartz will play a vital role in driving Dotmatics’ long-term strategic initiatives to continue to enhance the company’s value to its customers.

Dotmatics Names Michael Swartz as Chief Strategy Officer

Techstrong TV - Thomas Swalla

Learn about the innovative ways Dotmatics is harnessing AI to accelerate breakthroughs, streamline workflows, and empower scientists to tackle the most complex challenges in R&D. 

Techstrong TV: AI Leadership Insights for Scientific Research and Drug Discovery

Thumbnail-Techstrong TV

PR-BioGlyph

The strategic investment in BioGlyph enhances Dotmatics software offerings to support MsAb formats.

Dotmatics Announces Investment in BioGlyph for Visualizing, Illustrating, and Modeling Multispecific Antibodies

Dotmatics Announces Investment in BioGlyph for Designing, Registering, and Modeling Multispecific Antibodies

Dotmatics-msn

Learn about Dotmatics' journey, game-changing technology, and why Dotmatics is becoming an essential tool in the life sciences industry.

News & Media

Join Our Team Today